	How Selling Medicare Supplements Post-AEP Boosts Your Productivity If you’re a Medicare insurance agent, the Medicare Annual Enrollment Period (AEP) is probably your busiest season selling Medicare Advantage plans. The time after AEP can seem like a bit of a lull, but there is one sure-fire...
5 Marketing Strategies to Keep Your Agency Top-of-Mind You may have seen a decrease in your clients at your agency. You may have customarily gotten clients through social events and community events. It may be time to rethink and rework your agency’s marketing strategy.
	The Marketing S.W.O.T. Analysis Agent Pipeline is here to help you through making a Marketing S.W.O.T. Analysis. We have put together a PDF you can fill out to guide you through the important questions.
Social Media Pieces That Target Baby Boomers Baby Boomers are very active on social media platforms like Facebook! Agent Pipeline has created social media pieces you can use.

Upcoming Webinars

FEB

ACA 101

Join Us @ 2 PM EST. Let's go back to the basics and explore the fundamentals of the Affordable Care Act, and the essentials you need to know when selling ACA products.

FEB

Marketing to More Prospects

Your potential client pool is growing and changing – Join us, @ 2 PM EST, to discover tips to make sure you’re taking advantage of the best way to market to the Medicare-eligible community.

Industry News

2021 Special Enrollment Period in
response to the COVID-19 Emergency

The coronavirus disease 2019 (COVID-19) national emergency has presented unprecedented challenges for the American public. Millions of Americans are facing uncertainty and millions of Americans are experiencing new health problems during the pandemic. Read More...

Improving and Expanding Access
to Care and Treatments for COVID-19

By the authority vested in me as President by the Constitution and the laws of the United States of America,
it is hereby ordered as follows: Section 1. Policy. It is the policy of my Administration to improve the capacity
of the Nation's healthcare systems to address coronavirus disease 2019 (COVID-19), to accelerate the development of novel therapies to treat COVID-19, and to improve all Americans' access to quality
and affordable healthcare. Read More...